Kokmen E
Mayo Clin Proc. 1984 Jan;59(1):35-42. doi: 10.1016/s0025-6196(12)60340-1.
At least half of the patients who present with progressive decline in their memory, cognitive, and intellectual abilities will eventually be diagnosed as having Alzheimer's disease. The diagnosis is reached by clinical and ancillary evaluation and exclusion of all other causes of dementia. Recently, considerable advances have been made in our understanding of the neurobiologic features of Alzheimer's disease. Cortical neurons contain paired helical filaments with a very specific electron microscopic appearance. These filaments contain proteins with unusual properties. A severe decline in cholinergic activity in the cortex is related to a marked loss of cholinergic neurons in deep cerebral structures, such as the nucleus basalis of Meynert in the substantia innominata. No specific treatment is available for Alzheimer's disease. Patients and the relatives who take care of them require substantial help and assistance in coping with the disease.
至少一半出现记忆力、认知和智力能力逐渐衰退的患者最终会被诊断为患有阿尔茨海默病。该诊断通过临床及辅助评估并排除所有其他痴呆病因来达成。最近,我们对阿尔茨海默病的神经生物学特征的理解取得了相当大的进展。皮质神经元含有具有非常特殊电子显微镜外观的双螺旋丝。这些丝含有具有异常特性的蛋白质。皮质中胆碱能活性的严重下降与大脑深部结构中胆碱能神经元的显著丧失有关,如无名质中的迈内特基底核。目前尚无针对阿尔茨海默病的特效治疗方法。患者及其照顾亲属在应对该疾病时需要大量的帮助和支持。